Immuno-cell therapy with antecedent surgery has superior actuarial survival to immuno-cell therapy without antecedent surgery for advanced cancers. Sep 2011 - Cancer Immunol. Immunother.; 60(10):1432-0851 [PMID:21638124] [Shindo G] [Endo T] [Onda M] [Miyamoto Y] [Kaneko T] [Goto S]
